ArticleDiscover oncology2025

Dexmedetomidine and dezocine targets (NR1H3 and ADRB1) are potential prognostic biomarkers for breast cancer.

Shaochun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.